Pittenger & Anderson’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
Pittenger & Anderson's AUPH Position: Q3 2026 in Review
Pittenger & Anderson held its Aurinia Pharmaceuticals (AUPH) position steady in Q3 2026 at 1,000 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #383.
Pittenger & Anderson first reported a position in AUPH in Q4 2020 and has held it in 24 quarters since. The position peaked at $23K in Q4 2021. 277 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.
- Pittenger & Anderson held 1,000 shares of Aurinia Pharmaceuticals worth $16.2K as of Q3 2026.
- Pittenger & Anderson left its Aurinia Pharmaceuticals share count unchanged in Q3 2026.
- Aurinia Pharmaceuticals made up ﹤0.01% of Pittenger & Anderson's portfolio in Q3 2026, its #383 holding.
- Pittenger & Anderson first reported a position in Aurinia Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- Pittenger & Anderson's Aurinia Pharmaceuticals position peaked at $23K in Q4 2021.
- 277 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.
Based on Pittenger & Anderson's 13F filing for Q3 2026, filed 2 Nov 2026.